Next, the extent of p-ERK was revealed to be elevated in glioma cells in the presence of MAGT1 overexpression, and this elevation was abrogated when MAGT1 overexpression was combined with ERK inhibitor U0126 (Figure 4)). The gene discussed is MAGT1; the disease is central nervous system cancer.